Seeking Alpha

Sony (SNE) sets an ambitious goal of seeing its medical business churn up ¥200B ($2.6B) in...

Sony (SNE) sets an ambitious goal of seeing its medical business churn up ¥200B ($2.6B) in sales by 2020 after it sunk close to ¥50B into beleaguered Olympus Corp. The company is making a very serious bet that it will strike fortunes as the market for endoscopes expands rapidly.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector